logo
Plus   Neg
Share
Email

Stock Alert: Foley Trasimene Acquisition Touches New 52-week High

Shares of Foley Trasimene Acquisition Corp. II (BFT), a special purpose acquisition company, are gaining more than 5 percent or $0.88 in Thursday's morning trade at $18.35. The shares earlier hit a new 52-week high of $18.65 despite no company-centric news.

In early December, Foley Trasimene and Paysafe Group Holdings Limited, an integrated payments platform, said they have entered into a definitive agreement and plan of merger. The transaction reflects an implied pro-forma enterprise value for Paysafe of about $9 billion.

The transaction is expected to close in the first half of 2021. Upon closing of the transaction, the newly combined company will operate as Paysafe and plans to list on the New York Stock Exchange under the symbol "PSFE".

Foley Trasimene Acquisition has traded in a range of $9.60 to $18.65 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Editors Pick
CVS Pharmacy, the retail division of CVS Health, announced the availability of three over-the-counter or OTC COVID-19 testing options in stores and online. With these new-to-market home tests, customers will get access to convenient testing that can be conducted at home. The tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Tes United Airlines is adding three new flights to Croatia, Greece and Iceland, which are starting to reopen to vaccinated visitors. The move would give travelers more options for summer travel by flying direct to these countries. Last month's searches on United.com for flights to Croatia, Greece and Iceland were up 61 percent. Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden.
RELATED NEWS
Follow RTT